Literature DB >> 5917391

Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure.

D Athanassiadis, W I Cranston, B E Juel-Jensen, D O Oliver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5917391      PMCID: PMC1943934          DOI: 10.1136/bmj.2.5516.732

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT.

Authors:  D W RICHARDSON; A J HONOUR; G W FENTON; F H STOTT; G W PICKERING
Journal:  Clin Sci       Date:  1964-06       Impact factor: 6.124

2.  CLINICAL PHARMACOLOGICAL STUDIES WITH DEBRISOQUIN SULFATE, A NEW ANTIHYPERTENSIVE AGENT.

Authors:  W B ABRAMS; R POCELINKO; M KLAUSNER; L HANAUER; E N WHITMAN
Journal:  J New Drugs       Date:  1964 Sep-Oct

3.  CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.).

Authors:  R A MOE; H M BATES; Z M PALKOSKI; R BANZIGER
Journal:  Curr Ther Res Clin Exp       Date:  1964-04

4.  TREATMENT OF HYPERTENSION WITH DEBRISOQUIN SULFATE (DECLINAX).

Authors:  M H LURIA; E D FREIS
Journal:  Curr Ther Res Clin Exp       Date:  1965-05

5.  THE ROLE OF POSTGANGLIONIC SYMPATHETIC BLOCKADE IN ANTIHYPERTENSIVE THERAPY.

Authors:  J M BRYANT; L FLETCHER; N SCHVARTZ; H FERTIG; R B QUAN
Journal:  JAMA       Date:  1965-09-20       Impact factor: 56.272

  5 in total
  5 in total

1.  Today's Drugs: Debrisoquine.

Authors: 
Journal:  Br Med J       Date:  1968-01-20

2.  Macrosteres: The Deltic Guanidinium Ion.

Authors:  Kenji Mishiro; Fanghao Hu; Daniel W Paley; Wei Min; Tristan H Lambert
Journal:  European J Org Chem       Date:  2016-03-14

3.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

Review 4.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

5.  Outpatient treatment trial of mild and severe hypertension.

Authors:  K L Stuart; C MacIver; J A Nicholson
Journal:  Br Med J       Date:  1972-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.